Discontinuation of Antidepressants in Older Adults: A Literature Review

References

• Piau A, Huet Y, Gallini A, Andre L, Vellas B, Nourhashemi F. Optimization of drug therapy in elderly individuals admitted to a geriatric unit. Clin Interv Aging. 2017;12:1691–1696. doi:10.2147/CIA.S132309
   PubMed Web of Science ®Google Scholar
• Sladana P. Haute Autorité de santé. 2017:45.
   Google Scholar
• NICE. Overview | Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes | Guidance. NICE; 2021. Available from: https://www.nice.org.uk/guidance/ng5. Accessed March 21, 2023.
   Google Scholar
• Legrain S, Lacaille S. Prescription médicamenteuse du sujet âgé. EMC - Traité Médecine AKOS. 2006;1(1):1–7. doi:10.1016/S1634-6939(05)37740-4
   Google Scholar
• NICE. Overview | multimorbidity: clinical assessment and management | guidance. NICE; 2021. Available from: https://www.nice.org.uk/guidance/ng56. Accessed March 21, 2023.
   Google Scholar
• St Sauver JL, Boyd CM, Grossardt BR, et al. Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity. BMJ Open. 2015;5(2):e006413. doi:10.1136/bmjopen-2014-006413
   PubMed Web of Science ®Google Scholar
• NICE. Overview | depression in adults with a chronic physical health problem: recognition and management | guidance. NICE; 2021. Available from: https://www.nice.org.uk/guidance/cg91. Accessed March 21, 2023.
   Google Scholar
• NICE. Overview | depression in adults: recognition and management | guidance. NICE; 2021. Available from: https://www.nice.org.uk/guidance/cg90. Accessed March 21, 2023.
   Google Scholar
• Pitchot W, Scantamburlo G, Pinto E, Ansseau M. syndrome de discontinuation associé aux antidépresseurs [Discontinuation syndrome associated with antidepressants]. Rev Med Liege. 2007;62(10):624–627. French.
   PubMedGoogle Scholar
• Kok RM, Reynolds CF. Management of depression in older adults: a review. JAMA. 2017;317(20):2114. doi:10.1001/jama.2017.5706
   PubMed Web of Science ®Google Scholar
• Krause M, Gutsmiedl K, Bighelli I, Schneider-Thoma J, Chaimani A, Leucht S. Efficacy and tolerability of pharmacological and non-pharmacological interventions in older patients with major depressive disorder: a systematic review, pairwise and network meta-analysis. Eur Neuropsychopharmacol. 2019;29(9):1003–1022. doi:10.1016/j.euroneuro.2019.07.130
   PubMed Web of Science ®Google Scholar
• Tham A, Jonsson U, Andersson G, Söderlund A, Allard P, Bertilsson G. Efficacy and tolerability of antidepressants in people aged 65 years or older with major depressive disorder – a systematic review and a meta-analysis. J Affect Disord. 2016;205:1–12. doi:10.1016/j.jad.2016.06.013
   PubMed Web of Science ®Google Scholar
• Gers L, Petrovic M, Perkisas S, Vandewoude M. Antidepressant use in older inpatients: current situation and application of the revised STOPP criteria. Ther Adv Drug Saf. 2018;9(8):373–384. doi:10.1177/2042098618778974
   PubMed Web of Science ®Google Scholar
• Gutsmiedl K, Krause M, Bighelli I, Schneider-Thoma J, Leucht S. How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysis. BMC Psychiatry. 2020;20(1):102. doi:10.1186/s12888-020-02514-2
   PubMed Web of Science ®Google Scholar
• Mallery L, MacLeod T, Allen M, et al. Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: questionable benefit and considerations for frailty. BMC Geriatr. 2019;19(1):306. doi:10.1186/s12877-019-1327-4
   PubMed Web of Science ®Google Scholar
• Sobieraj DM, Martinez BK, Hernandez AV, et al. Adverse effects of pharmacologic treatments of major depression in older adults. J Am Geriatr Soc. 2019;67(8):1571–1581. doi:10.1111/jgs.15966
   PubMed Web of Science ®Google Scholar
• Holvast F, Massoudi B, Oude Voshaar RC, Verhaak PFM. Non-pharmacological treatment for depressed older patients in primary care: a systematic review and meta-analysis. PLoS One. 2017;12(9):e0184666. doi:10.1371/journal.pone.0184666
   PubMed Web of Science ®Google Scholar
• Jonsson U, Bertilsson G, Allard P, et al. Psychological treatment of depression in people aged 65 years and over: a systematic review of efficacy, safety, and cost-effectiveness. PLoS One. 2016;11(8):e0160859. doi:10.1371/journal.pone.0160859
   PubMed Web of Science ®Google Scholar
• Kok RM. What is the role of medications in late life depression? Psychiatr Clin North Am. 2013;36(4):597–605. doi:10.1016/j.psc.2013.08.006
   PubMed Web of Science ®Google Scholar
• Nervenheilkunde (DGPPN) DGFP Psychotherapie Und, Ärztliches Zentrum Für Qualität In Der Medizin (ÄZQ). S3-leitlinie/nationale versorgungsleitlinie unipolare depression - langfassung, 2. Auflage. [Neurology, Psychotherapy and, Medical Center for Quality in Medicine (ÄZQ). S3 guideline/national care guideline for unipolar depression - long version, 2nd edition. German Society for Psychiatry, Psychotherapy and Neurology (DGPPN); German Medical Association (BÄK); National Association of Statutory Health Insurance Physicians (KBV); Association of Scientific Medical Societies (AWMF)]; 2015. Available from: http://www.leitlinien.de/mdb/downloads/nvl/depression/depression-2aufl-vers5-lang.pdf. Accessed March 21, 2023.
   Google Scholar
• Lang PO, Hasso Y, Drame M, et al. Potentially inappropriate prescribing including under-use amongst older patients with cognitive or psychiatric co-morbidities. Age Ageing. 2010;39(3):373–381. doi:10.1093/ageing/afq031
   PubMed Web of Science ®Google Scholar
• Beekman ATF, Spijker J. Personalised diagnostiek en behandeling van depressie [Personalised diagnosis and treatment of depression]. Tijdschr Voor Psychiatr. 2018;60(3):156–160. Dutch.
   PubMedGoogle Scholar
• Scogin F, Rohen N, Bailey E. Geriatric depression scale. In: Handbook of Psychological Assessment in Primary Care Settings. Mahwah, NJ, US: Lawrence Erlbaum Associates Publishers; 2000:491–508.
   Google Scholar
• Kroenke K, Spitzer RL, Williams JBW. The PHQ-9. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.016009606.x
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62.
   PubMed Web of Science ®Google Scholar
• Black K, Shea C, Dursun S, Kutcher S. Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci. 2000;25(3):255–261.
   PubMed Web of Science ®Google Scholar
• Kuyken W, Hayes R, Barrett B, et al. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet. 2015;386(9988):63–73. doi:10.1016/S0140-6736(14)62222-4
   PubMed Web of Science ®Google Scholar
• Thomas P, Hazif-Thomas C. Dépression chez la personne âgée [Depression in elderly]. Rev Prat. 2008;58(4):389–393. French.
   PubMedGoogle Scholar
• Simpson S, Baldwin RC, Jackson A, Burns AS. Is subcortical disease associated with a poor response to antidepressants? Neurological, neuropsychological and neuroradiological findings in late-life depression. Psychol Med. 1998;28(5):1015–1026. doi:10.1017/S003329179800693X
   PubMed Web of Science ®Google Scholar
• Flint AJ, Rifat SL. Anxious depression in elderly patients: response to antidepressant treatment. Am J Geriatr Psychiatry. 1997;5(2):107–115.
   PubMed Web of Science ®Google Scholar
• Herron JW, Mitchell A. Depression and antidepressant prescribing in the elderly. Prescriber. 2018;29(3):12–17. doi:10.1002/psb.1654
   Google Scholar
• Fulone I, Lopes LC. Potentially inappropriate prescriptions for elderly people taking antidepressant: comparative tools. BMC Geriatr. 2017;17(1):278. doi:10.1186/s12877-017-0674-2
   PubMedGoogle Scholar
• Avasthi A, Grover S. Clinical practice guidelines for management of depression in elderly. Indian J Psychiatry. 2018;60(Suppl 3):S341–S362. doi:10.4103/0019-5545.224474
   PubMed Web of Science ®Google Scholar
• Gadzhanova S, Roughead EE, Pont LG. Antidepressant switching patterns in the elderly. Int Psychogeriatr. 2018;30(9):1365–1374. doi:10.1017/S1041610217002964
   PubMed Web of Science ®Google Scholar
• Keks N, Hope J, Keogh S. Switching and stopping antidepressants. Aust Prescr. 2016;39(3):76–83. doi:10.18773/austprescr.2016.039
   PubMedGoogle Scholar
• Outhoff K. Switching antidepressants. South Afr Fam Pract. 2015;2(57):32‑4.
   Google Scholar
• McCue RE. Using tricyclic antidepressants in the elderly. Clin Geriatr Med. 1992;8(2):323–334.
   PubMedGoogle Scholar
• Chatterjee S, Bali V, Carnahan RM, Chen H, Johnson ML, Aparasu RR. Anticholinergic medication use and risk of fracture in elderly adults with depression. J Am Geriatr Soc. 2016;64(7):1492–1497. doi:10.1111/jgs.14182
   PubMed Web of Science ®Google Scholar
• Kodesh A, Sandin S, Reichenberg A, et al. Exposure to antidepressant medication and the risk of incident dementia. Am J Geriatr Psychiatry. 2019;27(11):1177–1188. doi:10.1016/j.jagp.2019.05.019
   PubMed Web of Science ®Google Scholar
• Heser K, Luck T, Röhr S, et al. Potentially inappropriate medication: association between the use of antidepressant drugs and the subsequent risk for dementia. J Affect Disord. 2018;226:28–35. doi:10.1016/j.jad.2017.09.016
   PubMed Web of Science ®Google Scholar
• Kostev K, Rex J, Eith T, Heilmaier C. Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients. Ger Med Sci. 2014;12:Doc15.
   PubMedGoogle Scholar
• Beers MH. Explicit criteria for determining inappropriate medication use in nursing home residents. Arch Intern Med. 1991;151(9):1825. doi:10.1001/archinte.1991.00400090107019
   PubMedGoogle Scholar
• Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83. doi:10.5414/CPP46072
   PubMed Web of Science ®Google Scholar
• O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2014;44(2):213–218. doi:10.1093/ageing/afu145
   PubMed Web of Science ®Google Scholar
• By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults: 2019 AGS BEERS CRITERIA® UPDATE EXPERT PANEL. J Am Geriatr Soc. 2019;67(4):674–694. doi:10.1111/jgs.15767
   PubMed Web of Science ®Google Scholar
• Lang PO, Dramé M, Guignard B, et al. Les critères STOPP/START.v2: adaptation en langue française [The STOPP/START.v2 criteria: adaptation in French language]. NPG Neurol. 2015;15(90):323–336.
   Google Scholar
• Curtain CM, Bindoff IK, Westbury JL, Peterson GM. A comparison of prescribing criteria when applied to older community-based patients. Drugs Aging. 2013;30(11):935–943. doi:10.1007/s40266-013-0116-6
   PubMed Web of Science ®Google Scholar
• Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171(11). doi:10.1001/archinternmed.2011.215
   PubMedGoogle Scholar